233 related articles for article (PubMed ID: 17905619)
41. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
42. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism.
Levy BD; Lukacs NW; Berlin AA; Schmidt B; Guilford WJ; Serhan CN; Parkinson JF
FASEB J; 2007 Dec; 21(14):3877-84. PubMed ID: 17625069
[TBL] [Abstract][Full Text] [Related]
43. [Effects of montelukast on apoptosis and Fas mRNA expression of eosinophils in airway of asthmatic guinea pigs].
Wu YQ; Zhou CH; Zhang HQ
Yao Xue Xue Bao; 2004 Oct; 39(10):769-73. PubMed ID: 15700813
[TBL] [Abstract][Full Text] [Related]
44. Cysteinyl leukotriene-dependent interleukin-5 production leading to eosinophilia during late asthmatic response in guinea-pigs.
Nabe T; Yamashita K; Miura M; Kawai T; Kohno S
Clin Exp Allergy; 2002 Apr; 32(4):633-40. PubMed ID: 11972613
[TBL] [Abstract][Full Text] [Related]
45. Allergen challenge-induced changes in bone-marrow responses to leukotriene D
Masid-de-Brito D; Vieira BM; de Souza CC; Silva F; Gaspar-Elsas MIC; Xavier-Elsas P
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):199-210. PubMed ID: 32122206
[No Abstract] [Full Text] [Related]
46. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
47. Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro.
Tsang F; Koh AH; Ting WL; Wong PT; Wong WS
Br J Pharmacol; 1998 Sep; 125(1):61-8. PubMed ID: 9776345
[TBL] [Abstract][Full Text] [Related]
48. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
49. Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generation.
Kushiya M; Saito K; Kikuchi I; Kobayashi T; Hagiwara K; Kanazawa M; Nagata M
Int Arch Allergy Immunol; 2006; 140 Suppl 1():17-22. PubMed ID: 16772722
[TBL] [Abstract][Full Text] [Related]
50. Montelukast exerts no acute direct effect on NO synthases.
Hamacher J; Eichert K; Braun C; Grebe T; Strub A; Lucas R; Eltze M; Wendel A
Pulm Pharmacol Ther; 2007; 20(5):525-33. PubMed ID: 16815057
[TBL] [Abstract][Full Text] [Related]
51. Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma.
Sakata K; Bäck M
Eur J Pharmacol; 2002 Feb; 436(1-2):119-26. PubMed ID: 11834255
[TBL] [Abstract][Full Text] [Related]
52. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
53. Effects of nebulised magnesium sulphate on inflammation and function of the guinea-pig airway.
Turner DL; Ford WR; Kidd EJ; Broadley KJ; Powell C
Eur J Pharmacol; 2017 Apr; 801():79-85. PubMed ID: 28284753
[TBL] [Abstract][Full Text] [Related]
54. Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle.
Fogli S; Stefanelli F; Martelli A; Daniele S; Testai L; Calderone V; Trincavelli ML; Martini C; Breschi MC
Pulm Pharmacol Ther; 2013 Dec; 26(6):693-9. PubMed ID: 23810957
[TBL] [Abstract][Full Text] [Related]
55. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
[TBL] [Abstract][Full Text] [Related]
56. Effect of FK3657, a non-peptide bradykinin B2 receptor antagonist, on allergic airway disease models.
Hirayama Y; Miyayasu K; Yamagami K; Imai T; Ohkubo Y; Mutoh S
Eur J Pharmacol; 2003 Apr; 467(1-3):197-203. PubMed ID: 12706475
[TBL] [Abstract][Full Text] [Related]
57. [Allergen-induced late bronchoconstriction and airway hyperresponsiveness in guinea pigs].
Hoshino H; Kobayashi H; Konno S; Okazawa A; Okada Y; Suganuma T; Maruyama S; Adachi M; Takahashi T
Arerugi; 1989 Apr; 38(4):314-25. PubMed ID: 2783033
[TBL] [Abstract][Full Text] [Related]
58. Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility.
Corriveau S; Rousseau É; Blouin S; Pasquier JC
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():77-83. PubMed ID: 24735655
[TBL] [Abstract][Full Text] [Related]
59. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3.
Kiwamoto T; Ishii Y; Morishima Y; Yoh K; Kikuchi N; Haraguchi N; Masuko H; Kawaguchi M; Nomura A; Sakamoto T; Takahashi S; Hizawa N
Clin Exp Allergy; 2011 Jan; 41(1):116-28. PubMed ID: 20636401
[TBL] [Abstract][Full Text] [Related]
60. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
